ROLE OF HUMAN T LYMPHOTROPIC VIRUS TYPE I ON PATHOGENESIS OF SJOGREN'S SYNDROME

I型人类T淋巴细胞病毒在干燥综合征发病机制中的作用

基本信息

  • 批准号:
    07670534
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

Human T-cell lymphotropic virus type I (HTLV-I) is a human retrovirus, originally identified as an aetiological agent of adult T cell leukemia, and closely associated with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). We previously demonstrated that the HTLV-I seroprevalence in Sjogren's syndrome (SS) patients was 23.0%, which was significantly higher than those of the normal blood donors (3.4%). The age-adjusted summary odds ratio of HTLV-I infection in SS patients as compared with normal blood donors, estimated by the Mantel-Haenszel procedure, was 3.1. Furthermore, etiologic fraction, the proportion of SS patients attributable to HTLV-I infection, was estimated to be 17.6%.At first, we investigated whether SS was complicated with HAM patients. The clinical feature and histological findings of SS and the prevalence of serum autoantibodies were examined 14 patients with HAM.All patients with HAM histologically showed a mononuclear cell infiltration in the labial … More salivary glands. According to the preliminary criteria for SS proposed by the European Community, definitive SS was diagnosed in 8 patients and probable SS in 4 patients. There was no significant difference in the prevalence of autoantibodies including rheumatoid factor, anti-nuclear, anti-SS-A (Ro) and anti-SS-B (La) antibodies among 8 HAM patients with definitive SS,HTLV-I-seropositive and- seronegative SS patients. The CD4^+ T cells preferentially infiltrated into the salivary glands in HAM patients as well as the salivary glands of patients with HTLV-I-seropositive and -seronegative patients.Next, apoptosis in labial salivary glands from HTLV-I-seropositive and -seronegative SS patients was studied. Apoptotic cell death was detected in epithelial cells (acinus and ducts) of labial salivary glands. Fas antigen was found on epithelial cells in labial salivary glands. Fas ligand was stained in the infiltrated lymphocytes. There was no significant difference in above findings between HTLV-I-seropositive and -seronegative SS patients.We examined the presence of HTLV-I provirus DNA of both peripheral blood lymphocytes and labial salivary glands form 7 HTLV-I seropositive patients with SS by nested two-step PCR.All 4 independent regions of the HTLV-I genomic, including LTR,gag, pol and pX,were readily amplified from DNA of peripheral blood lymphocytes and tissues of all the seropositive patients. Next, we studied the copy number of HTLV-I in each sample DNA by semiquantitative PCR.The ratio of the copy number between tissue and lymphocytes was variable, but 3 out of 4 SS patients without HAM gene very high values. These findings suggest that HTLV-I infected cells may accumulate in the salivary gland of these patients. From the above findings, it seems likely that peripheral blood T cells from HAM patients preferentially infiltrate into the salivary glands, and then the infiltrated T cells induce SS the pathological changes in the exocrine organs. We studied, therefore, transmigratory activity of circulating T cells from HAM patients through reconstituted basement membrane. Transmigratory activity of lymphocytes was assayd in Transwell cell-culture chambers. We applied the circulating CD4^+ cells from patients with HAM and normal subjects on Transwell cell-culture chambers, and then counted the number of transmigrated cells. The percentage of transmigrated CD4^+ cells from HAM patients was significantly higher than that from normal subjects. Furthermore, HTLV-I proviral DNA quantified in the transmigrated CD4^+ cells from HAM patients were 2 to 8 fold more frequent than that in the non-transmigrated CD4^+ cells. These findings indicate that HTLV-I infected CD4^+ cells of HAM patients have up-regulated transmigratory activity through reconstituted basement membrane.In summary, our findings strongly support the idea that HTLV-I is involved in the pathogenesis of the disease in a subset of patients with SS in endemic areas. Less
人T淋巴细胞趋化病毒I型(HTLV-I)是一种人类逆转录病毒,最初被认为是成人T细胞白血病的病原体,与HTLV-I相关性脊髓病/热带痉挛麻痹(HAM/TSP)密切相关。我们先前证实干燥综合征(SS)患者HTLV-I血清阳性率为23.0%,显著高于正常献血员(3.4%)。用Mantel-Haenszel程序估计,SS患者与正常献血者相比,年龄调整后HTLV-I感染的汇总优势比为3.1。此外,病原学分数,即SS患者可归因于HTLV-I感染的比例,估计为17.6%。首先,我们调查了SS是否合并HAM患者。对14例HAM患者的临床表现、组织学特点及血清自身抗体的检测结果进行了分析。HAM患者的唇部…均有单个核细胞的浸润更多的唾液腺。根据欧洲共同体提出的SS初步诊断标准,确诊SS 8例,可能SS 4例。类风湿因子、抗核、抗SS-A(Ro)和抗SS-B(La)等自身抗体在8例确诊SS、HTLV-I阳性和血清阴性SS患者中的阳性率无显著差异。HAM患者的唾液腺和HTLV-I阳性及血清阴性患者的唾液腺中均有CD4~+T细胞优先渗入。唇腺上皮细胞(腺泡和导管)可见细胞凋亡。Fas抗原定位于唇涎腺上皮细胞。Fas配体在浸润性淋巴细胞中染色。用套式两步聚合酶链式反应检测了7例HTLV-I阳性SS患者外周血淋巴细胞和唾液腺组织中HTLV-I前病毒DNA的存在。接下来,我们用半定量聚合酶链式反应研究了HTLV-I在每个样本DNA中的拷贝数,组织和淋巴细胞的拷贝数比例是可变的,但4例无HAM基因的SS患者中有3例拷贝数很高。这些发现表明,HTLV-I感染细胞可能在这些患者的唾液腺中积聚。由此可见,HAM患者外周血中的T细胞可能首先侵入唾液腺,然后由浸润的T细胞引起外分泌器官病变。因此,我们研究了HAM患者循环T细胞通过重组基底膜的迁移活性。在Transwell细胞培养箱中检测淋巴细胞的迁移活性。我们将HAM患者和正常人的外周血中的CD4~+细胞置于Transwell细胞培养箱中,然后计数移植细胞的数量。HAM患者外周血中移行的CD4~+细胞百分率显著高于正常人。此外,HAM患者移行的CD4^+细胞中HTLV-I前病毒DNA定量的频率是未移行的CD4^+细胞的2~8倍。这些发现表明,HTLV-I感染的HAM患者的CD4^+细胞通过重组基底膜具有上调的迁移活性。综上所述,我们的研究结果有力地支持了HTLV-I参与了流行区SS患者亚群的疾病发病机制。较少

项目成果

期刊论文数量(124)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kiyoshi Migita,et al: "The role of protein kinase in human synovial fibroblast growth" Biochem Biophs Res Commun. 210(3). 1066-1075 (1995)
Kiyoshi Migita 等人:“蛋白激酶在人滑膜成纤维细胞生长中的作用”Biochem Biophs Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomoki Origuchi,et al: "Synovial cells are potent antigen-presenting cells for superantigens,staphylococcal enterotoxin B" Clinical and Experimental Immunology. 99(3). 345-351 (1995)
Tomoki Origuchi 等人:“滑膜细胞是超级抗原、葡萄球菌肠毒素 B 的有效抗原呈递细胞”临床和实验免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masako Kita,et al: "Abnormal liver function in patients with Sjogren's syndrome" Acta Med Nagasaki. 41(3-4). 31-37 (1996)
Masako Kita 等人:“干燥综合征患者的肝功能异常”Acta Med Nagasaki。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiro Izumi,et al: "Premature fat deposition in salivary glanda effected by Sjogren's syndrome : evidence by MR and CT" Am J Neuroradiol. (accepted). (1997)
Masahiro Izumi 等人:“干燥综合征影响唾液腺过早脂肪沉积:MR 和 CT 证据”Am J Neuroradiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Eguchi, N.Matsuoka, et al: "Cellular immunity in autoimmune thyroid disease" Bailliere's Clin Endoc. 9 (1). 71-94 (1995)
K.Eguchi、N.Matsuoka 等人:“自身免疫性甲状腺疾病中的细胞免疫”Bailliere 的 Clin Endoc。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EGUCHI Katsumi其他文献

EGUCHI Katsumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EGUCHI Katsumi', 18)}}的其他基金

Role of innate immunity on initiation of autoimmune diseases and its regulation
先天免疫在自身免疫性疾病发生中的作用及其调控
  • 批准号:
    15390316
  • 财政年份:
    2003
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome
HTLV-I相关干燥综合征易感基因及发病机制分析
  • 批准号:
    13557042
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of immunoregulation by serine proteinase inhibitor and its application of therapy for rheumatic disease
丝氨酸蛋白酶抑制剂的免疫调节机制及其在风湿病治疗中的应用
  • 批准号:
    13670461
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of Fas mediated apoptosis in the process of autoimmune thyroid diseases : possible involvement of Fas ligand (FasL) expression in breakdown of "immunoprevileged site" formation
Fas 介导的细胞凋亡在自身免疫性甲状腺疾病过程中的作用:Fas 配体 (FasL) 表达可能参与“免疫抑制位点”形成的破坏
  • 批准号:
    11671091
  • 财政年份:
    1999
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HTLV-I on pathegenesis of Sjogren's syndrome
HTLV-I 在干燥综合征发病机制中的作用
  • 批准号:
    09670482
  • 财政年份:
    1997
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of adult T cell lymphotropic virus 1 on pathogenesis of Sjogren's syndrome.
成人 T 细胞嗜淋巴细胞病毒 1 在干燥综合征发病机制中的作用。
  • 批准号:
    05670426
  • 财政年份:
    1993
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Role of HTLV-I infection in development of chronic inflammatory arthropathy.
HTLV-I 感染在慢性炎症性关节病发展中的作用。
  • 批准号:
    02670285
  • 财政年份:
    1990
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
  • 批准号:
    10644080
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome
衰老和氧化应激对干燥综合征唾液腺疾病的影响
  • 批准号:
    10682148
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10854472
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10528045
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
利用分子特征为干燥综合征提供个性化 B 细胞靶向治疗
  • 批准号:
    MR/X004694/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10646349
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10524424
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10685136
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10657745
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Development of remote support program to improve sleep quality and fatigue in patients with Sjogren's syndrome
开发远程支持计划以改善干燥综合征患者的睡眠质量和疲劳
  • 批准号:
    21K10778
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了